Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Relapsing-remitting multiple sclerosis
ADR ID BADD_A08687
ADR Hierarchy
17      Nervous system disorders
17.16      Demyelinating disorders
17.16.01      Multiple sclerosis acute and progressive
17.16.01.007      Relapsing-remitting multiple sclerosis
Description The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914) [MeSH]
MedDRA Code 10063399
MeSH ID D020529
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Relapsing-remitting multiple sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Relapsing Remitting | Remitting-Relapsing Multiple Sclerosis | Multiple Sclerosis, Remitting-Relapsing | Remitting Relapsing Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Multiple Sclerosis, Acute Relapsing | Acute Relapsing Multiple Sclerosis
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00680Dimethyl fumarate0.006281%
BADD_D01433Methylprednisolone--
BADD_D02165Teriflunomide0.000482%
BADD_D02464Fingolimod0.002291%
BADD_D02473Sodium chloride--
BADD_D02511Siponimod0.000482%
The 1th Page    1    Total 1 Pages